These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6087827

  • 1. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.
    Schwartz PM, Novack J, Shipman C, Drach JC.
    Biochem Pharmacol; 1984 Aug 01; 33(15):2431-8. PubMed ID: 6087827
    [Abstract] [Full Text] [Related]

  • 2. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
    Schwartz PM, Shipman C, Drach JC.
    Antimicrob Agents Chemother; 1976 Jul 01; 10(1):64-74. PubMed ID: 185947
    [Abstract] [Full Text] [Related]

  • 3. The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness?
    Drach JC, Shipman C.
    Ann N Y Acad Sci; 1977 Mar 04; 284():396-409. PubMed ID: 212984
    [Abstract] [Full Text] [Related]

  • 4. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
    Shipman C, Smith SH, Carlson RH, Drach JC.
    Antimicrob Agents Chemother; 1976 Jan 04; 9(1):120-7. PubMed ID: 176927
    [Abstract] [Full Text] [Related]

  • 5. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
    Smith SH, Shipman C, Drach JC.
    Cancer Res; 1978 Jul 04; 38(7):1916-21. PubMed ID: 207416
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
    Williams BB, Bailey EJ, Lerner AM.
    J Lab Clin Med; 1977 Apr 04; 89(4):687-91. PubMed ID: 191546
    [Abstract] [Full Text] [Related]

  • 7. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.
    Aswell JF, Allen GP, Jamieson AT, Campbell DE, Gentry GA.
    Antimicrob Agents Chemother; 1977 Aug 04; 12(2):243-54. PubMed ID: 197886
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems.
    Müller WE, Zahn RK, Bittlingmaier K, Falke D.
    Ann N Y Acad Sci; 1977 Mar 04; 284():34-48. PubMed ID: 212980
    [Abstract] [Full Text] [Related]

  • 9. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
    Williams BB, Lerner AM.
    J Infect Dis; 1975 Jun 04; 131(6):673-7. PubMed ID: 166117
    [Abstract] [Full Text] [Related]

  • 10. In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.
    Kreis W, Damin L, Colacino J, Lopez C.
    Biochem Pharmacol; 1982 Mar 01; 31(5):767-73. PubMed ID: 7082345
    [Abstract] [Full Text] [Related]

  • 11. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Plunkett W, Benjamin RS, Keating MJ, Freireich EJ.
    Cancer Res; 1982 May 01; 42(5):2092-6. PubMed ID: 6175407
    [Abstract] [Full Text] [Related]

  • 12. Differential and selective inhibition of cellular and herpes simplex virus DNA synthesis by arabinofuranosyladenine.
    Falke D, Ronge K, Arendes J, Müller WE.
    Biochim Biophys Acta; 1979 Jun 20; 563(1):36-45. PubMed ID: 227462
    [Abstract] [Full Text] [Related]

  • 13. DNA polymerase in nuclei isolated from herpes simplex virus type-2-infected cells. Characterization of the reaction product and inhibition by substrate analogs.
    Barnett JW, Reinke CM, Turk SR, Drach JC.
    Biochim Biophys Acta; 1984 Feb 24; 781(1-2):130-42. PubMed ID: 6320890
    [Abstract] [Full Text] [Related]

  • 14. Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.
    Fleming HE, Coen DM.
    Antimicrob Agents Chemother; 1984 Sep 24; 26(3):382-7. PubMed ID: 6095755
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan 24; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.
    Smee DF, Boehme R, Chernow M, Binko BP, Matthews TR.
    Biochem Pharmacol; 1985 Apr 01; 34(7):1049-56. PubMed ID: 3872662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.